February Resource Roundup

February Resource Roundup
Welcome to our monthly resource roundup! Each month, we’ll be curating study opportunities, new clinical trials, research results, news articles, personal perspectives, and upcoming events of interest to women and families affected by breast, ovarian, or metastatic breast cancer.

Ovarian Cycle NYC

SHARE is excited to announce that we’re partnering with the Ovarian Cancer Research Alliance (OCRA) for the 2019 Ovarian Cycle NYC! This fun and exciting indoor cycling challenge will take place on Saturday, May 4, and is open to participants of all ages and experience level.

January 2019 Resource Roundup

Welcome to our new, monthly resource roundup! Each month, we’ll be curating study opportunities, new clinical trials, research results, news articles, personal perspectives, and upcoming events of interest to women and families affected by breast, ovarian, or metastatic breast cancer.

September is Ovarian Cancer Awareness Month

Join SHARE in spreading what real survivors wish people knew about ovarian cancer during 2018's Ovarian Cancer Awareness Month!

The American Cancer Society estimates one in 78 women will be diagnosed with ovarian cancer in their lifetime.

We Run For Hope 2018

Runners and walkers from around the city gathered at Flushing Meadows Park on Sunday, June 4, for the We Run for Hope 5K/10K Run and Walk. This event, held annually on National Cancer Survivors Day, is a great opportunity to support women with breast or ovarian cancer while also staying fit and active.

FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy as a Treatment for Women with Advanced Ovarian Cancer Following Initial Surgery

Avastin is now approved for ten distinct uses across six different types of cancer in the United States.

SOUTH SAN FRANCISCO, Calif. – June 13, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection.

May 8 is World Ovarian Cancer Day!

On May 8, people around the world are gathering to support awareness of ovarian cancer. Join SHARE by following us on Facebook, Twitter, and Instagram, where we’ll be posting about signs, symptoms, and stories you can share with the women in your life.

National Helpline:
844-ASK-SHARE